These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors. Author: Hwang JY, Kim HY, Jo S, Park E, Choi J, Kong S, Park DS, Heo JM, Lee JS, Ko Y, Choi I, Cechetto J, Kim J, Lee J, No Z, Windisch MP. Journal: Eur J Med Chem; 2013; 70():315-25. PubMed ID: 24177358. Abstract: In order to identify novel anti-hepatitis C virus (HCV) agents we devised cell-based strategies and screened phenotypically small molecule chemical libraries with infectious HCV particles, and identified a hit compound (1) containing a hexahydropyrimidine (HHP) core. During our cell-based SAR study, we observed a conversion of HHP 1 into a linear diamine (6), which is the active component in inhibiting HCV and exhibited comparable antiviral activity to the cyclic HHP 1. In addition, we engaged into the biological characterization of HHP and demonstrated that HHP does not interfere with HCV RNA replication, but with entry and release of viral particles. Here we report the results of the preliminary SAR and mechanism of action studies with HHP.[Abstract] [Full Text] [Related] [New Search]